Provided by Tiger Trade Technology Pte. Ltd.

Viking Therapeutics

37.87
+3.068.79%
Post-market: 37.78-0.0900-0.24%19:58 EDT
Volume:5.58M
Turnover:207.09M
Market Cap:4.38B
PE:-9.10
High:38.08
Open:35.63
Low:35.03
Close:34.81
52wk High:43.15
52wk Low:22.96
Shares:115.55M
Float Shares:110.00M
Volume Ratio:1.72
T/O Rate:5.07%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1600
EPS(LYR):-3.1920
ROE:-70.04%
ROA:-42.54%
PB:8.72
PE(LYR):-11.86

Loading ...

Analysts Are Bullish on Top Healthcare Stocks: Silexion Therapeutics (SLXN), Viking Therapeutics (VKTX)

TIPRANKS
·
9 hours ago

Viking catalysts include VK3019, VK2735 readouts in Q3, says Raymond James

TIPRANKS
·
Yesterday

Viking Therapeutics: Advancing Obesity Pipeline Supports Buy Rating and Unchanged $102 Price Target

TIPRANKS
·
Yesterday

Viking Therapeutics Begins Phase 1 Testing of Investigational Weight Loss Drug

MT Newswires Live
·
Yesterday

Viking Therapeutics begins Phase 1 SAD clinical trial of VK3019

TIPRANKS
·
Yesterday

Viking Therapeutics Says FDA Clears IND for Vk3019 Obesity Drug Trial

Reuters
·
Yesterday

Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist Vk3019 in Healthy Adults

THOMSON REUTERS
·
Yesterday

Viking Therapeutics - to Initiate Phase 3 Trial of Oral Vk2735 Later This Year

THOMSON REUTERS
·
Yesterday

Viking Therapeutics - Expects to Report Vk2735 Dosing Study Results in 3Q26

THOMSON REUTERS
·
Yesterday

Viking Therapeutics (VKTX) Stock Could Be 67.2% Undervalued After Analysts Back VK2735

Simply Wall St.
·
Jun 20

Viking Therapeutics call volume above normal and directionally bullish

TIPRANKS
·
Jun 18

Viking Therapeutics management to meet with B. Riley

TIPRANKS
·
Jun 16

Is Viking’s New CMO Appointment Reframing the VK2735 Investment Case for Viking Therapeutics (VKTX)?

Simply Wall St.
·
Jun 14

Viking Therapeutics appoints Hubert Chen as chief medical officer

Reuters
·
Jun 11

Viking Therapeutics Announces Appointment of Hubert C. Chen, M.d., as Chief Medical Officer

THOMSON REUTERS
·
Jun 11

Viking Therapeutics files Form 3 for Chief Medical Officer Hubert C. Chen

Reuters
·
Jun 04

Analyst Reiterates Buy on Viking Therapeutics, Citing Best-in-Class Obesity Pipeline and Multiple Value-Creation Catalysts

TIPRANKS
·
Jun 03

Viking Therapeutics Initiated at Buy by Lake Street

Dow Jones
·
May 29

Lake Street Initiates Viking Therapeutics With Buy Rating, $89 Price Target

MT Newswires Live
·
May 28

Viking Therapeutics (VKTX) Initiated with a Buy at Truist Financial

TIPRANKS
·
May 27